David R. Sage

1.3k total citations
12 papers, 892 citations indexed

About

David R. Sage is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, David R. Sage has authored 12 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in David R. Sage's work include Viral-associated cancers and disorders (6 papers), Cytomegalovirus and herpesvirus research (3 papers) and Immune Cell Function and Interaction (3 papers). David R. Sage is often cited by papers focused on Viral-associated cancers and disorders (6 papers), Cytomegalovirus and herpesvirus research (3 papers) and Immune Cell Function and Interaction (3 papers). David R. Sage collaborates with scholars based in United States, China and Israel. David R. Sage's co-authors include Joyce D. Fingeroth, Bruce J. Dezube, Erik Gustafson, Towia A. Libermann, Kimberly E. Foreman, Jay W. Shin, Satoshi Hirakawa, Michael Detmar, Young-Kwon Hong and Christine L. Curry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Blood.

In The Last Decade

David R. Sage

12 papers receiving 871 citations

Peers

Countries citing papers authored by David R. Sage

Since Specialization

Citations

This map shows the geographic impact of David R. Sage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Sage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Sage more than expected).

Fields of papers citing papers by David R. Sage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Sage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Sage. The network helps show where David R. Sage may publish in the future.

Co-authorship network of co-authors of David R. Sage

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Sage. A scholar is included among the top collaborators of David R. Sage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Sage. David R. Sage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)–MYC Interaction 2023 ·Journal of Medicinal Chemistry ·Jian Ding, Lulu Liu, Ying‐Ling Chiang, Mengxi Zhao, Hejun Liu, Fengtang Yang, Lingling Shen, Ying Lin, (unknown), Jingyan Gao, David R. Sage, Laura Ciaccia West, Luis Llamas, Xin Hao, Sameer Kawatkar, En Li, Rishi K. Jain, John A. Tallarico, Stephen M. Canham, (unknown)	11
2	Analysis of Host Gene Expression Changes Reveals Distinct Roles for the Cytoplasmic Domain of the Epstein-Barr Virus Receptor/CD21 in B-Cell Maturation, Activation, and Initiation of Virus Infection 2014 ·Journal of Virology ·Mohamed S. Arredouani, Manoj Bhasin, David R. Sage, Laura Dunn, Michael B. Gill, (unknown), Towia A. Libermann, Joyce D. Fingeroth	6
3	The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9 2008 ·Acta Crystallographica Section D Biological Crystallography ·Raviraj Kulathila, (unknown), David R. Sage, Susan Cornell-Kennon, (unknown), James A. Koehn, Travis Stams, Kirk Clark, Allen C. Price	28
4	A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-α Signaling 2007 ·Cancer Research ·Alex Gaither, Dale Porter, Yao Yao, Jason Borawski, Guang Yang, Jerry Donovan, David R. Sage, Joanna Slisz, Mary Tran, Christopher Straub, (unknown), Vadim Iourgenko, Alan Huang, Yan Chen, Robert Schlegel, Mark Labow, Stephen E. Fawell, William R. Sellers, Leigh Zawel	178
5	Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus 2004 ·Nature Genetics ·Young-Kwon Hong, Kimberly E. Foreman, Jay W. Shin, Satoshi Hirakawa, Christine L. Curry, David R. Sage, Towia A. Libermann, Bruce J. Dezube, Joyce D. Fingeroth, Michael Detmar	280
6	EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21 2004 ·Journal of Cell Science ·Michael B. Gill, Jennifer Roecklein‐Canfield, David R. Sage, (unknown), (unknown), Marc E. Uknis, Joyce D. Fingeroth	23
7	The crystal structure of human CD21: Implications for Epstein–Barr virus and C3d binding 2002 ·Proceedings of the National Academy of Sciences ·A.E. Prota, David R. Sage, Thilo Stehle, Joyce D. Fingeroth	65
8	Characterization of Kaposi sarcoma–associated herpesvirus/human herpesvirus–8 infection of human vascular endothelial cells: early events 2002 ·Blood ·Bruce J. Dezube, (unknown), David R. Sage, (unknown), Joyce D. Fingeroth	38
9	Epstein-Barr Virus Encodes a Novel Homolog of thebcl-2Oncogene That Inhibits Apoptosis and Associates with Bax and Bak 1999 ·Journal of Virology ·William L. Marshall, (unknown), Erik Gustafson, Thomas Graf, David R. Sage, (unknown), (unknown), Joyce D. Fingeroth, Robert W. Finberg	132
10	CD21-Dependent Infection of an Epithelial Cell Line, 293, by Epstein-Barr Virus 1999 ·Journal of Virology ·Joyce D. Fingeroth, Margaret E. Diamond, David R. Sage, (unknown), John L. Yates	64
11	A Versatile Prokaryotic Cloning Vector with Six Dual Restriction Enzyme Sites in the Polylinker Facilitates Efficient Subcloning into Vectors with Unique Cloning Sites 1998 ·Plasmid ·David R. Sage, Antoinette Chillemi, Joyce D. Fingeroth	3
12	The Epstein-Barr Virus Thymidine Kinase Does Not Phosphorylate Ganciclovir or Acyclovir and Demonstrates a Narrow Substrate Specificity Compared to the Herpes Simplex Virus Type 1 Thymidine Kinase 1998 ·Antimicrobial Agents and Chemotherapy ·Erik Gustafson, Antoinette Chillemi, David R. Sage, Joyce D. Fingeroth	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact